Table: Wakamoto Pharm -2025/26 parent results

Wakamoto Pharmaceutical Co

15/05/2026 08:04

May 15 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           9.91            7.79           11.00                 
               (+27.2 pct)     (+0.7 pct)     (+11.0 pct)              
  Operating      255 mln      loss 457 mln      200 mln                
                                              (-21.7 pct)              
  Recurring      256 mln      loss 409 mln      200 mln                
                                              (-22.0 pct)              
  Net            227 mln         64 mln         230 mln                
              (+252.6 pct)     (-40.9 pct)    (+1.2 pct)               
  EPS           6.54 yen        1.85 yen       6.62 yen                
  Ann Div       3.50 yen        3.00 yen       3.50 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       3.50 yen        3.00 yen       3.50 yen                
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T